Submission Number: 561795-00002
Received: 8/13/2012 3:34:44 PM
Commenter: Clyde Dinkins
Agency: Federal Trade Commission
Initiative: 16 CFR Part 801; Premerger Notification; Reporting and Waiting Period Requirements; Project No. P989316
Attachments: No Attachments
I support proposed amendments to the premerger notification rules ("the Rules") to provide a framework for determining when a transaction involving the transfer of rights to a patent in the pharmaceutical, including biologics, and medicine manufacturing industry (North American Industry Classification System Industry Group 3254) ("pharmaceutical industry") is reportable under the Hart Scott Rodino Act ("the Act" or "HSR").
It.s further my position, said amendments are long overdue.